What is LOPJLB’s current signal on COLL?

LOPJLB publishes daily direction and regime signals for COLL on this page.

What market regime is COLL in?

LOPJLB classifies each ticker into BULL, RECOVERY, BEAR, or CRISIS regimes using a Hidden Markov Model.

What does Collegium Pharmaceutical, Inc. (COLL) do?

Collegium Pharmaceutical, Inc. (COLL) is a specialized pharmaceutical firm dedicated to the development and marketing of medications for pain management. Its diverse product lineup features significant therapies aimed at addressing various pain conditions. A prominent offering is Xtampza ER, an extended-release, oral formulation of oxycodone, specifically engineered with properties to deter abu…

Collegium Pharmaceutical, Inc. (COLL)

COMPARE

Healthcare · Drug Manufacturers - Specialty & Generic · NASDAQ · US

COLL

Loading signal…

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $698M
Short % float: 17.21%

Days to cover: 6.1
SI change: -2.8%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

FAQ

What is LOPJLB’s current signal on COLL?: LOPJLB publishes daily direction and regime signals for COLL on this page.
What market regime is COLL in?: LOPJLB classifies each ticker into BULL, RECOVERY, BEAR, or CRISIS regimes using a Hidden Markov Model.
What does Collegium Pharmaceutical, Inc. (COLL) do?: Collegium Pharmaceutical, Inc. (COLL) is a specialized pharmaceutical firm dedicated to the development and marketing of medications for pain management. Its diverse product lineup features significant therapies aimed at addressing various pain conditions. A prominent offering is Xtampza ER, an extended-release, oral formulation of oxycodone, specifically engineered with properties to deter abu…